A new experience with encapsulating peritoneal sclerosis role of early intervention tahere sadat kalantarian, iraj najafi after 20 years of peritoneal dialysis in iran, we have encountered with several cases of encapsulating peritoneal sclerosis eps in past few years. Encapsulating peritoneal sclerosis eps, a condition in which a fibrous cocoon has surrounded the bowel loops 1, is an uncommon but devastating complication of chronic peritoneal dialysis pd. Although relatively rare, encapsulating peritoneal sclerosis eps is nonetheless a major concern within the renal community. Length of time on peritoneal dialysis and encapsulating. Widespread calcification of the peritoneal reflections. The aim of the study was to establish a method to standardize and facilitate the differentiation between simple sclerosis and eps. Treatment for eps about treatment and the benefits of surgery. No reliable tests currently exist to identify patients at high risk of developing eps. There have been many reports of the incidence of eps being strongly correlated to the duration of pd. Towards detecting the adhesive cocoon of encapsulating. Encapsulating peritoneal sclerosis eps is a rare but serious complication of peritoneal dialysis. Background encapsulating peritoneal sclerosis eps is a rare but serious complication of longterm peritoneal dialysis pd. Encapsulating peritoneal sclerosis eps is a devastating complication of. Development of encapsulating peritoneal sclerosis following.
Although crosssectional imaging with computed tomography of the abdomen. Sclerosing encapsulating peritonitis may be confused with congenital peritoneal encapsulation, which is characterized by a thin accessory peritoneal sac surrounding the small bowel. Encapsulating peritoneal sclerosis eps is a rare cause of intestinal obstruction which is characterized by fibrotic encapsulation of the bowel due to a progressive intraabdominal inflammatory process. Imaging studies can be very important in confirming the diagnosis.
Treatment options for encapsulating peritoneal sclerosis based on progressive stage. The histological differentiation of those two entities is difficult. The incidence of eps in pd patients has been reported to be 2. Encapsulating peritoneal sclerosis eps is a debilitating condition characterized. A qualitative study to explore the experiences of patients. Encapsulating peritoneal sclerosis eps is a lifethreatening complication of longterm peritoneal dialysis pd, which may even occur after patients have switched to hemodialysis hd or undergone kidney transplantation. Encapsulating peritoneal sclerosis eps is a rare but serious complication of longterm peritoneal dialysis pd. May 01, 2011 read towards detecting the adhesive cocoon of encapsulating peritoneal sclerosis eps by cinemri. Causative factors are the chronic exposure to bioincompatible pd solutions, which cause longterm. Case discussion progressive calcifying peritonitis as a complication of ambulatory capd therapy in a young lady with renal failure secondary to diabetes.
Risk of developing eps is associated with longterm peritoneal dialysis. Encapsulating peritoneal sclerosis eps is a devastating but, fortunately, rare complication of longterm peritoneal dialysis. Morbidity and mortality are still high range from 25% to 55% especially in the first year after diagnosis. Effluent studies have yet to determine their value. Encapsulating peritoneal sclerosis eps is a potentially devastating complication of peritoneal dialysis pd. It is characterized by total or partial encasement of the small bowel within a thick fibrocollagenous membrane.
Magnetic nuclear imaging mri is a potentially useful tool, with similar results to scans. Encapsulating peritoneal sclerosis in the new millennium. Encapsulating peritoneal sclerosis eps is a rare but very severe complication of longterm peritoneal dialysis pd. Tamoxifen ameliorates peritoneal membrane damage by blocking. Peritoneal fibrosis peritoneal sclerosis sclerotic thickening of the peritoneal membrane. Encapsulating peritoneal sclerosis eps is a potentially lifethreatening condition that causes fibrocollagenous cocoonlike encapsulation of the bowel. A prospective, proteomics study identified potential. The national surgical service for encapsulating peritoneal sclerosis has two centres which are in cambridge and manchester.
Encapsulating peritoneal sclerosis a 5 year experience aim encapsulating peritoneal sclerosis eps is a rare, lifethreatening condition, characterised by a progressive, intraabdominal inflammatory process resulting in fibrotic visceral constriction. The most important risk factor for eps is duration of pd treatment, and associations have been found with younger age, frequent peritonitis, kidney transplantation and probably cessation of pd 1, 2. Histological criteria for encapsulating peritoneal sclerosis a. Although several medical and surgical treatment approaches exist, morbidity and mortality are still high. Since the first reports on this disease in the eighties, several imaging techniques have been used for its diagnosis. Encapsulating peritoneal sclerosis eps is a rare but devastating complication of longterm peritoneal dialysis pd. Ct scan, mri, and eventually laparoscopic inspection of the peritoneum, with a. Multicenter laparoscopic evaluation of the peritoneum in. The disease is associated with extensive thickening and fibrosis of the peritoneum resulting in the formation of a fibrous cocoon encapsulating the bowel leading to intestinal obstruction. Local representatives can answer questions about the profiles website or help with editing a profile or issues with profile data. Encapsulating peritoneal sclerosis is associated with tcell. Sheffield image registration toolkit was used to develop software for more. Little is known about longterm survivors with encapsulating peritoneal sclerosis eps.
Encapsulating peritoneal sclerosis in peritoneal dialysis. Encapsulating peritoneal sclerosis eps is a debilitating condition characterized by a fibrocollagenous membrane encasing the small intestine, resulting in recurrent small bowel obstructions. Encapsulating peritoneal sclerosis in children springerlink. Encapsulating peritoneal sclerosis as a late complication of. The diagnosis is clinical, relies on a constellation of symptoms, and can be confirmed radiologically. Incidence and outcomes of encapsulating peritoneal sclerosis. Ispd guidelines from 2000 2, felt the term encapsulating peritoneal sclerosis eps more accurately described the morphologic changes seen in this disorder. Eps can be considered an inflammatory repairing response of the peritoneum that has been damaged by chronic exposure to bioincompatible dialysis fluids. Akane foundation, tsuchiya general hospital, hiroshima, japan. A consecutive case series now totaling five patients with encapsulating peritoneal sclerosis suggests that tamoxifen is an effective treatment for this rare but often fatal complication of.
However, previous studies reported large variations in its mortality rates that may associate with a different degree of eps severity. Pdf imaging in encapsulating peritoneal sclerosis j. A new experience with encapsulating peritoneal sclerosis. Encapsulating peritoneal sclerosis eps is a lifethreatening complication of. Peritoneal fibrosis harvard catalyst profiles harvard. The incidence of eps varies across the globe and increases with pd vintage.
We therefore examined peritoneal effluent for potential biomarkers that could predict or confirm the diagnosis of eps and would be valuable in stratifying atrisk patients and driving appropriate. Jacqueline wolf harvard catalyst profiles harvard catalyst. Mesothelialtomesenchymal transition mmt is an autoregulated physiological process of tissue repair that in uncontrolled conditions such as peritoneal dialysis pd can lead to peritoneal fibrosis. Fortytwo cases 91% had diagnostic imaging table 4 and 29 63% had a. This asymptomtic condition is generally found incidentally during unrelated surgery and does not fit with the clinical or imaging findings in this group of patients.
Encapsulating peritoneal sclerosis eps represents a rare complication in. Nov 07, 2012 the two most relevant pathologies of longterm peritoneal dialysis pd are simple sclerosis and encapsulating peritoneal sclerosis eps. Encapsulating peritoneal sclerosis associated with peritoneal dialysis. Forty two cases 91% had diagnostic imaging table 4 and 29 63% had a. Encapsulating peritoneal sclerosis eps is a rare but devastating complication of peritoneal dialysis pd. A pilot study, gastroenterology on deepdyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips.
Encapsulating peritoneal sclerosis eps is a rare complication of peritoneal dialysis pd, resulting in significant morbidity and mortality. Other terms used to describe this entity include 8,9. Encapsulating peritoneal sclerosis eps is an uncommon and often fatal. Hideki kawanishi, yoshiko harada, toshio noriyuki, toru kawai, syunsuke takahashi, misaki moriishi, shinichiro tsuchiya from. There is no wellvalidated method for predicting which patients will develop the condition, although known risk factors include long duration of pd, high glucose exposure and lack of residual renal function. While eps has been well recognized in adults on longterm pd, and children can spend many years on pd before a transplant becomes available, only a small number of children with eps have been described. Encapsulating peritoneal sclerosis eps is a rare but devastating. Encapsulating peritoneal sclerosis eps is a lifethreatening complication of longterm peritoneal dialysis pd, which may even occur after patients have. Encapsulating peritoneal sclerosis presents after withdrawal from pd in the majority 70 90% in some series of patients 11,51 and the time from cessation of pd until the development of eps has been reported as up to 5 years. Chronic peritoneal dialysis pd can be complicated by encapsulating peritoneal sclerosis eps, a rare but the most severe complication associated with longterm pd. Terminology the condition was originally termed abdominal cocoon.
Peritoneal fibrosis is a descriptor in the national library of medicines controlled vocabulary thesaurus, mesh medical subject headings. This study reports the incidence and outcomes of eps and identifies the risk factors associated with severe eps. Research into eps continues to focus on imaging and early detection methods, genetics, biomarkers and. Dialysate cytokine levels do not predict encapsulating. Since the first peritoneal dialysis pd patients with encapsulating peritoneal sclerosis eps were reported in 1980, eps has been considered primarily a fatal complication. Pdf imaging features of encapsulating peritoneal sclerosis. Your doctor may use imaging tests or lab tests to analyze the peritoneal fluid to. Eps is most commonly associated with longterm peritoneal dialysis, though medications, peritoneal infection, and systemic inflammatory disorders have been implicated.
Frontiers encapsulating peritoneal sclerosisa rare but. Encapsulating peritoneal sclerosis a 5 year experience. The maximum expression of peritoneal fibrosis induced by pd fluids and other peritoneal processes is the encapsulating peritoneal sclerosis eps for which no specific treatment exists. Imaging in encapsulating peritoneal sclerosis clinical. Long pd duration and chronic exposure to dialysis solutions are considered risk factors for its development 24. Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity. Ijms free fulltext encapsulating peritoneal sclerosis. Clinical symptoms, radiologic findings, and histological criteria are the three diagnostic pillars of eps. Encapsulating peritoneal sclerosiseps, aetiology and pathogenesiseps, imaging techniquesinternational registryperitoneal. Encapsulating peritoneal sclerosiseps, aetiology and pathogenesis eps, imaging techniquesinternational registryperitoneal. Since the first reports on this disease in the eighties, several imaging. The number of patients using continuous ambulatory pd has remained low because of complications such as infectious peritonitis and encapsulating peritoneal sclerosis eps. Longterm peritoneal dialysis and encapsulating peritoneal.
Encapsulating peritoneal sclerosis eps is the most serious complication of longterm peritoneal dialysis pd, with a mortality rate that exceeds 30%. Firstly owtschinnikow described this condition as peritonitis chronica fibrosa incapsulata in 1907. The purpose of this article is to present the spectrum of radiologic findings of encapsulating peritoneal sclerosis in patients undergoing continuous. Histological criteria for encapsulating peritoneal sclerosis. While the primary driver of obstructive symptoms in eps is. Encapsulating peritoneal sclerosis is a rare but severe condition, with a high incidence of mortality, and no feasible therapies have been developed. Diagnosis is often delayed due to the lack of effective and accurate diagnostic tools. Published literature focuses on patients managed surgically. Pyrroleimidazole polyamide targeting transforming growth. Tamoxifen may treat encapsulating peritoneal sclerosis in pd.
Eps occurs in response to a wide variety of inciting factors and in various other clinical conditions spanning the entire domain of medicine. Encapsulating peritoneal sclerosis is a rare benign cause of acute or subacute small bowel obstruction. Table 1 clinical findings in encapsulating peritoneal sclerosis findingclinical features references signs of ileus 6. Imaging features of encapsulating peritoneal sclerosis in. Nov 21, 20 encapsulating peritoneal sclerosis eps is a rare but extremely serious complication of peritoneal dialysis pd.
1348 514 27 312 617 1344 339 174 692 102 494 1474 1088 1421 313 1068 1456 276 637 554 1468 65 1508 686 76 51 924 612 658 262 782